Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
GLOBETECH PUBLISHING

Novel Gene Identified for Usher Syndrome

By Labmedica International staff writers
Posted on 17 Oct 2012
A novel type of gene has been identified and found to be associated with Usher syndrome, a hereditary disease in which affected individuals lose both hearing and vision.

Several genes associated with different types of Usher syndrome have been identified and most of these genes encode common structural and motor proteins that build sensory cells in the eye and inner ear.

A team of researchers from multiple institutions, led by those from the University of Cincinnati (OH, USA) studied 14 affected individuals from families with nonsyndromic deafness and two affected individuals from a family with Usher Syndrome. Peripheral blood samples or buccal swabs for genomic DNA extraction were collected from participating subjects.

The team identified a gene on chromosome 15 and determined that its mutations are responsible for nonsyndromic deafness and Usher syndrome type (USH1J). A calcium and integrin binding protein 2 (CIB2) was found to be interacting with other proteins associated with Usher syndrome. They established that CIB2 is localized at the tips of mechanosensory stereocilia of the inner ear hair cells, exactly where the conversion of sound waves into electrical signals occurs. They found that in Pakistan, CIB2 mutations are one of the prevalent genetic causes of nonsyndromic hearing loss. In the USA, approximately six in every 100,000 babies born have Usher syndrome.

The scientists concluded that CIB2 mutations underlie USH1J and nonsyndromic deafness. They speculated that because the Cib2 gene is concentrated in stereocilia and interacts with myosin VIIa and whirlin. The Cib2 morphants have reduced hair cell microphonic potential, and that CIB2 participates in calcium regulation in the mechanotransduction process. Their studies reveal that, in humans, Cib2 is critical for proper photoreceptor maintenance and function and that CIB2 has conserved roles in calcium homeostasis. The study was published on September 30, 2012, in the journal Nature Genetics.

Related Links:

University of Cincinnati



PURITAN MEDICAL
EUROIMMUN AG
Sekisui Diagnostics
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: Enzyme-linked immunosorbent kit (ELISA) specific for human copeptin (Photo courtesy of USCN Life Science).

Preeclampsia Biomarker Detected Very Early In Pregnancy

A biomarker has been discovered that could give expecting mothers and their doctors the first simple blood test to reliably predict that a pregnant woman may develop preeclampsia, at least as early as... Read more

Pathology

view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

Brain Tumor Chemotherapy Biomarkers Identified

Cancer researchers have identified a new biomarker that they believe can predict whether glioblastoma multiformes (GBMs), the most common and aggressive type of malignant brain tumor, will be susceptible... Read more

Lab Tech.

view channel
Image: The ADVIA Centaur XPT Immunoassay System delivers the results that clinicians depend upon for accurate diagnoses and better patient care (Photo courtesy of Siemens Healthcare).

Introduction of New Central Laboratory Clinical Analyzers Highlights Recent Lab Equipment Exposition

An impressive array of new automated analyzers for central diagnostic laboratories was unveiled at a recent lab equipment trade fair. The IFCC WorldLab exposition held June 22-26, 2014, in Istanbul... Read more

Industry News

view channel

EKF Wins Distribution Contract and Regulatory Approval for Target Regions

EKF Diagnostics Holdings (Cardiff, Wales, UK), an AIM-listed point-of-care, central laboratory and molecular diagnostics business, announced that it has signed a new distribution contract in China and that one of its OEM (original equipment manufacturer) partners has received further regulatory approval across several target... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.